SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-177723
Filing Date
2022-06-21
Accepted
2022-06-21 16:44:34
Documents
3
Group Members
ACCESS INDUSTRIES HOLDINGS LLCACCESS INDUSTRIES MANAGEMENT, LLCLEN BLAVATNIK

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d305681dsc13da.htm SC 13D/A 88285
2 EX-99.5 d305681dex995.htm EX-99.5 27734
3 EX-99.6 d305681dex996.htm EX-99.6 9279
  Complete submission text file 0001193125-22-177723.txt   127156
Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Subject) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92582 | Film No.: 221028697
SIC: 2834 Pharmaceutical Preparations

Mailing Address 40 WEST 57TH STREET 28TH FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH STREET 28TH FLOOR NEW YORK NY 10019 212-247-6400
AI Day1 LLC (Filed by) CIK: 0001863302 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A